1. Catalogs
  2. iCAD
  3. ProFound AI™ for Digital Breast Tomosynthesis
video corpo

ProFound AI™ for Digital Breast Tomosynthesis

ProFound AI™ for Digital Breast Tomosynthesis

ProFound AI™ for Digital Breast Tomosynthesis

Product catalog summary
Introduction
ProFound AI™ is a cutting-edge solution designed to enhance the efficiency and accuracy of digital breast tomosynthesis (DBT) readings. As DBT becomes the standard in breast cancer screening, it presents challenges due to the large volume of data and the need for precise interpretation.

Challenges
Radiologists face increased workloads and time demands when interpreting DBT cases. The rising incidence of cancer necessitates early detection while minimizing false positives and unnecessary recalls.

Solution Overview
ProFound AI™ offers a transformative approach to DBT reading by utilizing advanced deep learning and AI technology. It improves cancer detection rates, reduces false positives, and decreases reading times. Key performance metrics include:
  • 8.0% average increase in sensitivity
  • 6.9% average increase in specificity
  • 7.2% average reduction in recalls
  • 5.7% average improvement in radiologist AUC
  • 52.7% reduction in reading time
Certainty of Findings scores assist in prioritizing caseloads and clinical decision-making.

Clinical and Workflow Benefits
ProFound AI™ is compatible with leading DBT systems and provides significant clinical performance and workflow benefits. It assigns Certainty of Finding and Case Scores to each detection and case, aiding radiologists in decision-making.

Platform and Technology
The solution operates on the PowerLook server platform with NVIDIA GPUs, ensuring rapid processing and integration with existing imaging systems. This allows for efficient handling of 4-view tomosynthesis cases.

Regulatory Approvals
ProFound AI™ is FDA cleared, CE Mark approved, and Health Canada licensed, ensuring compliance with international standards.
See more

Catalog excerpts

ProFound AI™ for Digital Breast Tomosynthesis-1

for Digital Breast Tomosynthesis Challenge Digital breast tomosynthesis (DBT) is rapidly replacing full-field digital mammography in screening due to its clinical value in cancer detection. Although this advanced technology is becoming the standard of care, it presents significant challenges to radiologists. Clinicians are confronted by the workload and time required to accurately read the extensive amounts of data contained in DBT cases. Further, as incidence rates of cancer continue to rise, it is becoming increasingly more important to find cancer sooner, while reducing unnecessary recalls resulting from false positives. Solution ProFound AI™ for digital breast tomosynthesis is revolutionizing the DBT reading paradigm and presents a transformative solution to address these challenges. The high-performing, concurrent-read, cancer detection and workflow solution rapidly and accurately analyzes each tomosynthesis image, detecting both malignant soft tissue densities and calcifications with unrivaled accuracy. Built on the latest deep learning and artificial intelligence (AI) technology, ProFound AI is clinically proven to assist radiologists in addressing the challenges of reading tomosynthesis cases by: • Improving cancer detection rates • Reducing false positives and unnecessary patient recalls • Decreasing reading times Clinical Performance Benefits Workflow Benefits • 8.0% average increase in sensitivity • 52.7% reduction in reading time • 6.9% average increase in specificity • Certainty of Findings scores assist in prioritizing caseload and clinical decision-making • 7.2% average reduction in recalls • 5.7% average improvement in radiologist AUC Compatible with leading digital breast tomosynthesis systems Breast Health Solutions 1.866.280.2239 toll free | 1.603.882.5200 | [email protected] | www.icadm

 Open the catalog to page 1
ProFound AI™ for Digital Breast Tomosynthesis-2

Certainty of Finding and Case Scores The ProFound AI algorithm is trained to detect malignant soft tissue densities and calcifications. Certainty of Finding and Case Scores are assigned to each detection and each case respectively. Certainty of Finding and Case Scores are relative scores computed by the ProFound AI algorithm and represent the algorithm’s confidence that a detection or case is malignant. The scores are represented on a 0% to 100% scale. A higher score indicates a higher level of confidence in the malignancy of the detection or case. The scores are calibrated to a population of...

 Open the catalog to page 2

All ICAD catalogs and technical brochures

  1. PowerLook®

    2  Pages

  2. SecondLook®

    1  Page

  3. VeraLook®

    2  Pages

*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.